Familial chylomicronemia syndrome: The first case reported in Ecuador

Clínica e Investigación en Arteriosclerosis (English Edition) Pub Date : 2022-11-01 DOI:10.1016/j.artere.2022.10.004

Karla Johana Garay García , Ricardo Javier Chong Menendez , Juan Patricio Nogueira , Jefferson Santiago Piedra Andrade

{"title":"Familial chylomicronemia syndrome: The first case reported in Ecuador","authors":"Karla Johana Garay García , Ricardo Javier Chong Menendez , Juan Patricio Nogueira , Jefferson Santiago Piedra Andrade","doi":"10.1016/j.artere.2022.10.004","DOIUrl":null,"url":null,"abstract":"<div><p>Familial chylomicronemia<span> syndrome (FCS) is a genetic entity with autosomal recessive inheritance<span>. Mutations in genes (such as APOC2, APOAV, LMF-1, GPIHBP-1) that code for proteins that regulate the maturation, transport, or polymerization of lipoprotein lipase-1 are the most common causes, but not the only ones. The objective of this study was to report the first documented case in Ecuador.</span></span></p></div><div><h3>Clinical case</h3><p><span>A 38-year-old man presented with chronic hepatosplenomegaly, thrombocytopenia, pancreatic atrophy, and severe </span>hypertriglyceridemia<span><span> refractory to treatment. A molecular analysis was performed by </span>next generation sequencing<span> that determined a deficiency of Lipoprotein Lipase OMIM #238600 in homozygosis. Genetic confirmation is necessary in order to establish the etiology of HTGS for an adequate management of this pathology.</span></span></p></div>","PeriodicalId":100263,"journal":{"name":"Clínica e Investigación en Arteriosclerosis (English Edition)","volume":"34 6","pages":"Pages 326-329"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clínica e Investigación en Arteriosclerosis (English Edition)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2529912322000699","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Familial chylomicronemia syndrome (FCS) is a genetic entity with autosomal recessive inheritance. Mutations in genes (such as APOC2, APOAV, LMF-1, GPIHBP-1) that code for proteins that regulate the maturation, transport, or polymerization of lipoprotein lipase-1 are the most common causes, but not the only ones. The objective of this study was to report the first documented case in Ecuador.

Clinical case

A 38-year-old man presented with chronic hepatosplenomegaly, thrombocytopenia, pancreatic atrophy, and severe hypertriglyceridemia refractory to treatment. A molecular analysis was performed by next generation sequencing that determined a deficiency of Lipoprotein Lipase OMIM #238600 in homozygosis. Genetic confirmation is necessary in order to establish the etiology of HTGS for an adequate management of this pathology.

查看原文本刊更多论文

家族性乳糜微粒血症综合征:厄瓜多尔报告首例病例

家族性乳糜微粒血症综合征(FCS)是一种常染色体隐性遗传。基因突变(如APOC2、APOAV、LMF-1、GPIHBP-1)编码调节脂蛋白脂酶-1成熟、转运或聚合的蛋白质是最常见的原因，但不是唯一的原因。本研究的目的是报告厄瓜多尔第一例有记录的病例。临床病例:一名38岁男性，以慢性肝脾肿大、血小板减少、胰腺萎缩和严重高甘油三酯血症难治性表现。通过下一代测序进行分子分析，确定纯合子中脂蛋白脂肪酶OMIM #238600缺乏。遗传确认是必要的，以便建立HTGS的病因，以适当地管理这种病理。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clínica e Investigación en Arteriosclerosis (English Edition)

自引率

0.00%

发文量